BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 36521658)

  • 41. Cancer extracellular vesicles, tumoroid models, and tumor microenvironment.
    Eguchi T; Sheta M; Fujii M; Calderwood SK
    Semin Cancer Biol; 2022 Nov; 86(Pt 1):112-126. PubMed ID: 35032650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor-derived extracellular vesicles in breast cancer: From bench to bedside.
    Wang HX; Gires O
    Cancer Lett; 2019 Sep; 460():54-64. PubMed ID: 31233837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracellular Vesicles in the Development of Cancer Therapeutics.
    Sun H; Burrola S; Wu J; Ding WQ
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative Proteomic Profiling of Secreted Extracellular Vesicles from Breast Fibroadenoma and Malignant Lesions: A Pilot Study.
    Pane K; Quintavalle C; Nuzzo S; Ingenito F; Roscigno G; Affinito A; Scognamiglio I; Pattanayak B; Gallo E; Accardo A; Thomas G; Minic Z; Berezovski MV; Franzese M; Condorelli G
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extracellular Vesicles in the Tumour Microenvironment: Eclectic Supervisors.
    Cavallari C; Camussi G; Brizzi MF
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-coding RNA derived from extracellular vesicles in cancer immune escape: Biological functions and potential clinical applications.
    Huang M; Peng X; Yang L; Yang S; Li X; Tang S; Li B; Jin H; Wu B; Liu J; Li H
    Cancer Lett; 2021 Mar; 501():234-246. PubMed ID: 33186654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
    Nasiri Kenari A; Cheng L; Hill AF
    Methods; 2020 May; 177():103-113. PubMed ID: 31917274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extracellular Vesicles in Haematological Disorders: A Friend or a Foe?
    Lazana I
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy.
    De Sousa KP; Rossi I; Abdullahi M; Ramirez MI; Stratton D; Inal JM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1835. PubMed ID: 35898167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The extracellular vesicles targeting tumor microenvironment: a promising therapeutic strategy for melanoma.
    Li Y; Liu F
    Front Immunol; 2023; 14():1200249. PubMed ID: 37575250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Roles of Extracellular Vesicles in Malignant Melanoma.
    Cheng YC; Chang YA; Chen YJ; Sung HM; Bogeski I; Su HL; Hsu YL; Wang HD
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extracellular vesicle proteins as breast cancer biomarkers: Mass spectrometry-based analysis.
    Bandu R; Oh JW; Kim KP
    Proteomics; 2024 Jun; 24(11):e2300062. PubMed ID: 38829178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems.
    Gaurav I; Thakur A; Iyaswamy A; Wang X; Chen X; Yang Z
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Systematic Evaluation of Factors Affecting Extracellular Vesicle Uptake by Breast Cancer Cells.
    Stranford DM; Hung ME; Gargus ES; Shah RN; Leonard JN
    Tissue Eng Part A; 2017 Nov; 23(21-22):1274-1282. PubMed ID: 28586292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypoxic regulation of extracellular vesicles: Implications for cancer therapy.
    Yoo S; Choi S; Kim I; Kim IS
    J Control Release; 2023 Nov; 363():201-220. PubMed ID: 37739015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glioma-Derived Extracellular Vesicles - Far More Than Local Mediators.
    Tankov S; Walker PR
    Front Immunol; 2021; 12():679954. PubMed ID: 34135908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in therapeutic applications of extracellular vesicles.
    Wiklander OPB; Brennan MÁ; Lötvall J; Breakefield XO; El Andaloussi S
    Sci Transl Med; 2019 May; 11(492):. PubMed ID: 31092696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Engineering strategies for customizing extracellular vesicle uptake in a therapeutic context.
    Esmaeili A; Alini M; Baghaban Eslaminejad M; Hosseini S
    Stem Cell Res Ther; 2022 Mar; 13(1):129. PubMed ID: 35346367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extracellular vesicle-based drug delivery systems for cancer treatment.
    Walker S; Busatto S; Pham A; Tian M; Suh A; Carson K; Quintero A; Lafrence M; Malik H; Santana MX; Wolfram J
    Theranostics; 2019; 9(26):8001-8017. PubMed ID: 31754377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.